XTL Biopharmaceuticals announces stock split
Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion
Global M&A by the Numbers: Q2 2022
Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms
Infographic 2022 Top Tech Trends Shaping Corporations
XTL Biopharmaceuticals Ltd. announced a stock split that will take effect Feb. 10.
XTL Biopharmaceuticals' depositary share will represent 100 ordinary shares of the company at that date as opposed to 20 ordinary shares previously.
The split will help the company regain compliance with Nasdaq's listing requirements.